Evidence map›Paper›PMID 26204937›Full record

ArticleStem cell research & therapy2015

ROCK activity and the Gβγ complex mediate chemotactic migration of mouse bone marrow-derived stromal cells.

Caroline M Ryan, James A L Brown, Emer Bourke, Áine M Prendergast, Claire Kavanagh, Zhonglin Liu, Peter Owens, Georgina Shaw, Walter Kolch, Timothy O'Brien and 1 more

Open access · goldAbstract read
In one paragraph

Article in Stem cell research & therapy, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.9field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 13 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Dissecting molecular mechanisms underlying HStem cell research & therapy · 2020
    Article
  5. Article
  6. Article
  7. Review
  8. Human umbilical cord mesenchymal stem cells delivering sTRAIL home to lung cancer mediated by MCP-1/CCR2 axis and exhibit antitumor effects.Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine · 2016
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 2 countries.

Caroline M RyanRegenerative Medicine Institute (REMEDI), Biosciences, National University of Ireland Galway, University Road, Galway, Ireland. carolineryan_@hotmail.com.
James A L BrownRegenerative Medicine Institute (REMEDI), Biosciences, National University of Ireland Galway, University Road, Galway, Ireland. james.brown@nuigalway.ie.
Emer BourkeDiscipline of Pathology, School of Medicine, National University of Ireland Galway, University Road, Galway, Ireland. emer.bourke@nuigalway.ie.
Áine M PrendergastRegenerative Medicine Institute (REMEDI), Biosciences, National University of Ireland Galway, University Road, Galway, Ireland. aine.prendergast@hi-stem.de.
Claire KavanaghRegenerative Medicine Institute (REMEDI), Biosciences, National University of Ireland Galway, University Road, Galway, Ireland. claire.kavanagh2@gmail.com.
Zhonglin LiuDepartment of Radiology, University of Arizona, Tucson, AZ, 85724-5067, USA. zliu@email.arizona.edu.
Peter OwensCentre for Micro and Imaging, National University of Ireland Galway, University Road, Galway, Ireland. peter.owens@nuigalway.ie.
Georgina ShawRegenerative Medicine Institute (REMEDI), Biosciences, National University of Ireland Galway, University Road, Galway, Ireland. georgina.shaw@nuigalway.ie.
Walter KolchSystems Biology Ireland, UCD Conway Institute, University College Dublin, Belfield, Dublin 4, Ireland. walter.kolch@ucd.ie.
Timothy O'BrienRegenerative Medicine Institute (REMEDI), Biosciences, National University of Ireland Galway, University Road, Galway, Ireland. timothy.obrien@nuigalway.ie.
Frank P BarryRegenerative Medicine Institute (REMEDI), Biosciences, National University of Ireland Galway, University Road, Galway, Ireland. frank.barry@nuigalway.ie.
Ollscoil na Gaillimhe – University of Galway · IEUniversity College Dublin · IEUniversity of Arizona · US

Funding

CENTER FOR GAMMA RAY IMAGINGP41EB002035 · NIBIB · UNIVERSITY OF ARIZONA · PI BARRETT, HARRISON H, FURENLID, LARS R · 2003 to 2018
$17.7M
NIBIB NIH HHS P41 EB002035NIBIB NIH HHS P41EB002035
6 · The paper itself

Abstract

introductionBone marrow-derived stromal cells (BMSCs), also known as mesenchymal stem cells, are the focus of intensive efforts worldwide to elucidate their function and biology. Despite the importance of BMSC migration for their potential therapeutic uses, the mechanisms and signalling governing stem cell migration are still not fully elucidated.

methodsWe investigated and detailed the effects of MCP-1 activation on BMSCs by using inhibitors of G protein-coupled receptor alpha beta (GPCR αβ), ROCK (Rho-associated, coiled-coil containing protein kinase), and PI3 kinase (PI3K). The effects of MCP-1 stimulation on intracellular signalling cascades were characterised by using immunoblotting and immunofluorescence. The effectors of MCP-1-mediated migration were investigated by using migration assays (both two-dimensional and three-dimensional) in combination with inhibitors.

resultsWe established the kinetics of the MCP-1-activated signalling cascade and show that this cascade correlates with cell surface re-localisation of chemokine (C motif) receptor 2 (CCR2) (the MCP-1 receptor) to the cell periphery following MCP-1 stimulation. We show that MCP-1-initiated signalling is dependent on the activation of βγ subunits from the GPCR αβγ complex. In addition, we characterise a novel role for PI3Kγ signalling for the activation of both PAK and ERK following MCP-1 stimulation. We present evidence that the Gβγ complex is responsible for PI3K/Akt, PAK, and ERK signalling induced by MCP-1 in BMSCs. Importantly, we found that, in BMSCs, inhibition of ROCK significantly inhibits MCP-1-induced chemotactic migration, in contrast to previous reports in other systems.

conclusionsOur results indicate differential chemotactic signalling in mouse BMSCs, which has important implications for the translation of in vivo mouse model findings into human trials. We identified novel components and interactions activated by MCP-1-mediated signalling, which are important for stem cell migration. This work has identified additional potential therapeutic targets that could be manipulated to improve BMSC delivery and homing.

Indexed as

ChemotaxisAnimalsAntigensCells, CulturedChemokine CCL2Extracellular Signal-Regulated MAP KinasesGTP-Binding Protein beta SubunitsHumansMesenchymal Stem CellsMice, Inbred BALB CPhosphatidylinositol 3-KinasesPhosphorylationProtein Processing, Post-TranslationalReceptors, G-Protein-Coupledrho-Associated KinasesSignal TransductionAntigensCcl2 protein, mouseChemokine CCL2Extracellular Signal-Regulated MAP KinasesGTP-Binding Protein beta SubunitspericentrinPhosphatidylinositol 3-KinasesReceptors, G-Protein-Coupledrho-Associated Kinases

Identifiers

PMID26204937
PMCPMC4603944
OpenAlexW1497888393

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.